Stock Events

Stock Events

Quest Diagnostics 

$237.14
247
-$2.26-0.94% Friday 20:00
+$2.86+1.21%Friday 23:49After hours

Statistics

Day High
238.92
Day Low
236.43
52W High
247.19
52W Low
171.18
Volume
775,616
Avg. Volume
955,409
Mkt Cap
26.17B
P/E Ratio
22.95
Dividend Yield
1.45%
Dividend
3.44

Upcoming

Dividends

1.45%Dividend Yield
Jul 26
$0.86
Apr 26
$0.86
Jan 26
$0.80
Oct 25
$0.80
Jul 25
$0.80
10Y Growth
7.85%
5Y Growth
7.06%
3Y Growth
6.61%
1Y Growth
7.1%

Earnings

27OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
2.15
2.47
2.8
3.12
Expected EPS
2.869908
Actual EPS
N/A

Financials

8.99%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
11.04BRevenue
992MNet Income

Analyst Ratings

242.14Average Price Target
The highest estimate is 260.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
29%
Hold
71%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DGX. It's not an investment recommendation.
Apple
61
AAPL
Microsoft
58
MSFT
Johnson & Johnson
52
JNJ
Realty Income
51
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Neogenomics
NEO
Mkt Cap2.32B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

About

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Show more...
CEO
James E. Davis
Employees
57000
Country
United States
ISIN
US74834L1008
WKN
000904533

Listings

MI
IT
1QDX.MI
STU
DE
QDI.STU
LSE
GB
0KSX.LSE
F
DE
QDI.F

0 Comments

Share your thoughts

FAQ

What is Quest Diagnostics stock price today?▼
The current price of DGX is $237.14 USD — it has decreased by -0.94% in the past 24 hours. Watch Quest Diagnostics stock price performance more closely on the chart.
What is Quest Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Quest Diagnostics stocks are traded under the ticker DGX.
Is Quest Diagnostics stock price growing?▼
DGX stock has fallen by -2.32% compared to the previous week, the month change is a +0.55% rise, over the last year Quest Diagnostics has showed a +29.24% increase.
What is Quest Diagnostics market cap?▼
Today Quest Diagnostics has the market capitalization of 26.17B
When is the next Quest Diagnostics earnings date?▼
Quest Diagnostics is going to release the next earnings report on October 27, 2026.
What were Quest Diagnostics earnings last quarter?▼
DGX earnings for the last quarter are 3.12 USD per share, whereas the estimation was 2.82 USD resulting in a +10.53% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quest Diagnostics revenue for the last year?▼
Quest Diagnostics revenue for the last year amounts to 11.04B USD.
What is Quest Diagnostics net income for the last year?▼
DGX net income for the last year is 992M USD.
Does Quest Diagnostics pay dividends?▼
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.86 USD. As of today, Dividend Yield (FWD)% is 1.45%.
How many employees does Quest Diagnostics have?▼
As of September 05, 2026, the company has 57,000 employees.
In which sector is Quest Diagnostics located?▼
Quest Diagnostics operates in the Health & Wellness sector.
When did Quest Diagnostics complete a stock split?▼
The last stock split for Quest Diagnostics was on June 21, 2005 with a ratio of 2:1.
Where is Quest Diagnostics headquartered?▼
Quest Diagnostics is headquartered in SECAUCUS, United States.